- Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
- Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
- Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
- Accuray to Participate in the Jefferies Global Healthcare Conference 2024
- Accuray Reports Fiscal 2024 Third Quarter Financial Results
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
- Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
More ▼
Key statistics
On Wednesday, Accuray Inc (ARAY:NSQ) closed at 1.73, 18.16% above the 52 week low of 1.46 set on May 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.75 |
---|---|
High | 1.79 |
Low | 1.73 |
Bid | 1.69 |
Offer | 1.80 |
Previous close | 1.75 |
Average volume | 516.30k |
---|---|
Shares outstanding | 99.24m |
Free float | 95.79m |
P/E (TTM) | -- |
Market cap | 171.69m USD |
EPS (TTM) | -0.2197 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼